Cerebral aneurysm rupture is a devastating event resulting in subarachnoid hemorrhage
and is associated with significant morbidity and death. Up to 50% of individuals do not …

Over the past two decades, biodegradable metals (BMs) have emerged as promising
materials to fabricate temporary biomedical devices, with the purpose of avoiding potential …

The use of flow diverters is a rapidly growing endovascular approach for the treatment of
intracranial aneurysms. All FDA-approved flow diverters are composed of nitinol or cobalt …

Magnesium (Mg) alloy stents have been commercialized for the treatment of cardiovascular
diseases and extensively studied for possible implantation in major organs. However, the in …

Most acute ischemic stroke patients with large vessel occlusion require stent implantation for
complete recanalization. Yet, due to ischemia-reperfusion injury, over half of these patients …

OBJECTIVE Bioresorbable flow diverters (BRFDs) could significantly improve the
performance of next-generation flow diverter technology. In the current work, magnesium …

Background and purpose Despite significant technical advances, recanalization rates after
endovascular therapy of ruptured intracranial aneurysms (IAs) remain a clinical challenge. A …

Background Unlike clipping that forms an immediate barrier of blood flow into intracranial
aneurysms, endovascular treatments rely on thrombus organization and neointima …

Endovascular treatment for intracranial aneurysms gained importance over the past
decades, consequently there is an increased need of testing endovascular devices. Animal …

The treatment of intracranial aneurysms (IAs) has undergone a very significant
transformation in recent decades, and endovascular interventions have gradually become …